Global Recombinant Human Follicle-stimulating Hormone Supply, Demand and Key Producers, 2023-2029

Page: 106

Published Date: 19 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Recombinant Human Follicle-stimulating Hormone market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Recombinant Human Follicle-stimulating Hormone demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Human Follicle-stimulating Hormone, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Follicle-stimulating Hormone that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Human Follicle-stimulating Hormone total market, 2018-2029, (USD Million)
Global Recombinant Human Follicle-stimulating Hormone total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Recombinant Human Follicle-stimulating Hormone total market, key domestic companies and share, (USD Million)
Global Recombinant Human Follicle-stimulating Hormone revenue by player and market share 2018-2023, (USD Million)
Global Recombinant Human Follicle-stimulating Hormone total market by Type, CAGR, 2018-2029, (USD Million)
Global Recombinant Human Follicle-stimulating Hormone total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Recombinant Human Follicle-stimulating Hormone market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL and Scripps Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Follicle-stimulating Hormone market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Human Follicle-stimulating Hormone Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Human Follicle-stimulating Hormone Market, Segmentation by Type
    75IU
    150IU
    Others

Global Recombinant Human Follicle-stimulating Hormone Market, Segmentation by Application
    Infertility Treatment
    Assisted Reproductive Technology

Companies Profiled:
    Merck
    Ferring
    Livzon
    Gedeon Richter
    GenSci
    Teva
    ChangChun High & New Technology
    ABL
    Scripps Laboratories
    Alphamab Oncology
    Hunan Jingfeng Pharmaceutical
    Qilu Pharmaceutical
    Beijing SL Pharmaceutical

Key Questions Answered
1. How big is the global Recombinant Human Follicle-stimulating Hormone market?
2. What is the demand of the global Recombinant Human Follicle-stimulating Hormone market?
3. What is the year over year growth of the global Recombinant Human Follicle-stimulating Hormone market?
4. What is the total value of the global Recombinant Human Follicle-stimulating Hormone market?
5. Who are the major players in the global Recombinant Human Follicle-stimulating Hormone market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Recombinant Human Follicle-stimulating Hormone Introduction
    1.2 World Recombinant Human Follicle-stimulating Hormone Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Recombinant Human Follicle-stimulating Hormone Total Market by Region (by Headquarter Location)
        1.3.1 World Recombinant Human Follicle-stimulating Hormone Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)
        1.3.3 China Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)
        1.3.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)
        1.3.5 Japan Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)
        1.3.6 South Korea Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)
        1.3.7 ASEAN Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)
        1.3.8 India Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Human Follicle-stimulating Hormone Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Human Follicle-stimulating Hormone Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)
    2.2 World Recombinant Human Follicle-stimulating Hormone Consumption Value by Region
        2.2.1 World Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2018-2023)
        2.2.2 World Recombinant Human Follicle-stimulating Hormone Consumption Value Forecast by Region (2024-2029)
    2.3 United States Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)
    2.4 China Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)
    2.5 Europe Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)
    2.6 Japan Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)
    2.7 South Korea Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)
    2.8 ASEAN Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)
    2.9 India Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029)

3 World Recombinant Human Follicle-stimulating Hormone Companies Competitive Analysis
    3.1 World Recombinant Human Follicle-stimulating Hormone Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Recombinant Human Follicle-stimulating Hormone Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Recombinant Human Follicle-stimulating Hormone in 2022
        3.2.3 Global Concentration Ratios (CR8) for Recombinant Human Follicle-stimulating Hormone in 2022
    3.3 Recombinant Human Follicle-stimulating Hormone Company Evaluation Quadrant
    3.4 Recombinant Human Follicle-stimulating Hormone Market: Overall Company Footprint Analysis
        3.4.1 Recombinant Human Follicle-stimulating Hormone Market: Region Footprint
        3.4.2 Recombinant Human Follicle-stimulating Hormone Market: Company Product Type Footprint
        3.4.3 Recombinant Human Follicle-stimulating Hormone Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Recombinant Human Follicle-stimulating Hormone Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Recombinant Human Follicle-stimulating Hormone Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Recombinant Human Follicle-stimulating Hormone Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Recombinant Human Follicle-stimulating Hormone Consumption Value Comparison
        4.2.1 United States VS China: Recombinant Human Follicle-stimulating Hormone Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Recombinant Human Follicle-stimulating Hormone Companies and Market Share, 2018-2023
        4.3.1 United States Based Recombinant Human Follicle-stimulating Hormone Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Recombinant Human Follicle-stimulating Hormone Revenue, (2018-2023)
    4.4 China Based Companies Recombinant Human Follicle-stimulating Hormone Revenue and Market Share, 2018-2023
        4.4.1 China Based Recombinant Human Follicle-stimulating Hormone Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Recombinant Human Follicle-stimulating Hormone Revenue, (2018-2023)
    4.5 Rest of World Based Recombinant Human Follicle-stimulating Hormone Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Recombinant Human Follicle-stimulating Hormone Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Recombinant Human Follicle-stimulating Hormone Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Human Follicle-stimulating Hormone Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 75IU
        5.2.2 150IU
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2023)
        5.3.2 World Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2029)
        5.3.3 World Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Human Follicle-stimulating Hormone Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Infertility Treatment
        6.2.2 Assisted Reproductive Technology
    6.3 Market Segment by Application
        6.3.1 World Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2023)
        6.3.2 World Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2029)
        6.3.3 World Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Merck
        7.1.1 Merck Details
        7.1.2 Merck Major Business
        7.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product and Services
        7.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Merck Recent Developments/Updates
        7.1.6 Merck Competitive Strengths & Weaknesses
    7.2 Ferring
        7.2.1 Ferring Details
        7.2.2 Ferring Major Business
        7.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product and Services
        7.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Ferring Recent Developments/Updates
        7.2.6 Ferring Competitive Strengths & Weaknesses
    7.3 Livzon
        7.3.1 Livzon Details
        7.3.2 Livzon Major Business
        7.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product and Services
        7.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Livzon Recent Developments/Updates
        7.3.6 Livzon Competitive Strengths & Weaknesses
    7.4 Gedeon Richter
        7.4.1 Gedeon Richter Details
        7.4.2 Gedeon Richter Major Business
        7.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Services
        7.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Gedeon Richter Recent Developments/Updates
        7.4.6 Gedeon Richter Competitive Strengths & Weaknesses
    7.5 GenSci
        7.5.1 GenSci Details
        7.5.2 GenSci Major Business
        7.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product and Services
        7.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 GenSci Recent Developments/Updates
        7.5.6 GenSci Competitive Strengths & Weaknesses
    7.6 Teva
        7.6.1 Teva Details
        7.6.2 Teva Major Business
        7.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product and Services
        7.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Teva Recent Developments/Updates
        7.6.6 Teva Competitive Strengths & Weaknesses
    7.7 ChangChun High & New Technology
        7.7.1 ChangChun High & New Technology Details
        7.7.2 ChangChun High & New Technology Major Business
        7.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Services
        7.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 ChangChun High & New Technology Recent Developments/Updates
        7.7.6 ChangChun High & New Technology Competitive Strengths & Weaknesses
    7.8 ABL
        7.8.1 ABL Details
        7.8.2 ABL Major Business
        7.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product and Services
        7.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 ABL Recent Developments/Updates
        7.8.6 ABL Competitive Strengths & Weaknesses
    7.9 Scripps Laboratories
        7.9.1 Scripps Laboratories Details
        7.9.2 Scripps Laboratories Major Business
        7.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Services
        7.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Scripps Laboratories Recent Developments/Updates
        7.9.6 Scripps Laboratories Competitive Strengths & Weaknesses
    7.10 Alphamab Oncology
        7.10.1 Alphamab Oncology Details
        7.10.2 Alphamab Oncology Major Business
        7.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Services
        7.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Alphamab Oncology Recent Developments/Updates
        7.10.6 Alphamab Oncology Competitive Strengths & Weaknesses
    7.11 Hunan Jingfeng Pharmaceutical
        7.11.1 Hunan Jingfeng Pharmaceutical Details
        7.11.2 Hunan Jingfeng Pharmaceutical Major Business
        7.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Services
        7.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Hunan Jingfeng Pharmaceutical Recent Developments/Updates
        7.11.6 Hunan Jingfeng Pharmaceutical Competitive Strengths & Weaknesses
    7.12 Qilu Pharmaceutical
        7.12.1 Qilu Pharmaceutical Details
        7.12.2 Qilu Pharmaceutical Major Business
        7.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Services
        7.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Qilu Pharmaceutical Recent Developments/Updates
        7.12.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Beijing SL Pharmaceutical
        7.13.1 Beijing SL Pharmaceutical Details
        7.13.2 Beijing SL Pharmaceutical Major Business
        7.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Services
        7.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Beijing SL Pharmaceutical Recent Developments/Updates
        7.13.6 Beijing SL Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Human Follicle-stimulating Hormone Industry Chain
    8.2 Recombinant Human Follicle-stimulating Hormone Upstream Analysis
    8.3 Recombinant Human Follicle-stimulating Hormone Midstream Analysis
    8.4 Recombinant Human Follicle-stimulating Hormone Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Human Follicle-stimulating Hormone Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Recombinant Human Follicle-stimulating Hormone Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Recombinant Human Follicle-stimulating Hormone Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Recombinant Human Follicle-stimulating Hormone Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Recombinant Human Follicle-stimulating Hormone Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Recombinant Human Follicle-stimulating Hormone Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Recombinant Human Follicle-stimulating Hormone Players in 2022
    Table 12. World Recombinant Human Follicle-stimulating Hormone Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Recombinant Human Follicle-stimulating Hormone Company Evaluation Quadrant
    Table 14. Head Office of Key Recombinant Human Follicle-stimulating Hormone Player
    Table 15. Recombinant Human Follicle-stimulating Hormone Market: Company Product Type Footprint
    Table 16. Recombinant Human Follicle-stimulating Hormone Market: Company Product Application Footprint
    Table 17. Recombinant Human Follicle-stimulating Hormone Mergers & Acquisitions Activity
    Table 18. United States VS China Recombinant Human Follicle-stimulating Hormone Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Recombinant Human Follicle-stimulating Hormone Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Recombinant Human Follicle-stimulating Hormone Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Recombinant Human Follicle-stimulating Hormone Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Recombinant Human Follicle-stimulating Hormone Revenue Market Share (2018-2023)
    Table 23. China Based Recombinant Human Follicle-stimulating Hormone Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Recombinant Human Follicle-stimulating Hormone Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Recombinant Human Follicle-stimulating Hormone Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Recombinant Human Follicle-stimulating Hormone Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Recombinant Human Follicle-stimulating Hormone Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Recombinant Human Follicle-stimulating Hormone Revenue Market Share (2018-2023)
    Table 29. World Recombinant Human Follicle-stimulating Hormone Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Recombinant Human Follicle-stimulating Hormone Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2029) & (USD Million)
    Table 35. Merck Basic Information, Area Served and Competitors
    Table 36. Merck Major Business
    Table 37. Merck Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 38. Merck Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Merck Recent Developments/Updates
    Table 40. Merck Competitive Strengths & Weaknesses
    Table 41. Ferring Basic Information, Area Served and Competitors
    Table 42. Ferring Major Business
    Table 43. Ferring Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 44. Ferring Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Ferring Recent Developments/Updates
    Table 46. Ferring Competitive Strengths & Weaknesses
    Table 47. Livzon Basic Information, Area Served and Competitors
    Table 48. Livzon Major Business
    Table 49. Livzon Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 50. Livzon Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Livzon Recent Developments/Updates
    Table 52. Livzon Competitive Strengths & Weaknesses
    Table 53. Gedeon Richter Basic Information, Area Served and Competitors
    Table 54. Gedeon Richter Major Business
    Table 55. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 56. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Gedeon Richter Recent Developments/Updates
    Table 58. Gedeon Richter Competitive Strengths & Weaknesses
    Table 59. GenSci Basic Information, Area Served and Competitors
    Table 60. GenSci Major Business
    Table 61. GenSci Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 62. GenSci Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. GenSci Recent Developments/Updates
    Table 64. GenSci Competitive Strengths & Weaknesses
    Table 65. Teva Basic Information, Area Served and Competitors
    Table 66. Teva Major Business
    Table 67. Teva Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 68. Teva Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Teva Recent Developments/Updates
    Table 70. Teva Competitive Strengths & Weaknesses
    Table 71. ChangChun High & New Technology Basic Information, Area Served and Competitors
    Table 72. ChangChun High & New Technology Major Business
    Table 73. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 74. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. ChangChun High & New Technology Recent Developments/Updates
    Table 76. ChangChun High & New Technology Competitive Strengths & Weaknesses
    Table 77. ABL Basic Information, Area Served and Competitors
    Table 78. ABL Major Business
    Table 79. ABL Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 80. ABL Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. ABL Recent Developments/Updates
    Table 82. ABL Competitive Strengths & Weaknesses
    Table 83. Scripps Laboratories Basic Information, Area Served and Competitors
    Table 84. Scripps Laboratories Major Business
    Table 85. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 86. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Scripps Laboratories Recent Developments/Updates
    Table 88. Scripps Laboratories Competitive Strengths & Weaknesses
    Table 89. Alphamab Oncology Basic Information, Area Served and Competitors
    Table 90. Alphamab Oncology Major Business
    Table 91. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 92. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Alphamab Oncology Recent Developments/Updates
    Table 94. Alphamab Oncology Competitive Strengths & Weaknesses
    Table 95. Hunan Jingfeng Pharmaceutical Basic Information, Area Served and Competitors
    Table 96. Hunan Jingfeng Pharmaceutical Major Business
    Table 97. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 98. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Hunan Jingfeng Pharmaceutical Recent Developments/Updates
    Table 100. Hunan Jingfeng Pharmaceutical Competitive Strengths & Weaknesses
    Table 101. Qilu Pharmaceutical Basic Information, Area Served and Competitors
    Table 102. Qilu Pharmaceutical Major Business
    Table 103. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 104. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Qilu Pharmaceutical Recent Developments/Updates
    Table 106. Beijing SL Pharmaceutical Basic Information, Area Served and Competitors
    Table 107. Beijing SL Pharmaceutical Major Business
    Table 108. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Services
    Table 109. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of Recombinant Human Follicle-stimulating Hormone Upstream (Raw Materials)
    Table 111. Recombinant Human Follicle-stimulating Hormone Typical Customers
List of Figure
    Figure 1. Recombinant Human Follicle-stimulating Hormone Picture
    Figure 2. World Recombinant Human Follicle-stimulating Hormone Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Human Follicle-stimulating Hormone Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Recombinant Human Follicle-stimulating Hormone Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Recombinant Human Follicle-stimulating Hormone Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Recombinant Human Follicle-stimulating Hormone Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Recombinant Human Follicle-stimulating Hormone Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Recombinant Human Follicle-stimulating Hormone Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Recombinant Human Follicle-stimulating Hormone Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Recombinant Human Follicle-stimulating Hormone Revenue (2018-2029) & (USD Million)
    Figure 13. Recombinant Human Follicle-stimulating Hormone Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Recombinant Human Follicle-stimulating Hormone by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Follicle-stimulating Hormone Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Follicle-stimulating Hormone Markets in 2022
    Figure 27. United States VS China: Recombinant Human Follicle-stimulating Hormone Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Recombinant Human Follicle-stimulating Hormone Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type in 2022
    Figure 31. 75IU
    Figure 32. 150IU
    Figure 33. Others
    Figure 34. World Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2018-2029)
    Figure 35. World Recombinant Human Follicle-stimulating Hormone Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application in 2022
    Figure 37. Infertility Treatment
    Figure 38. Assisted Reproductive Technology
    Figure 39. Recombinant Human Follicle-stimulating Hormone Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Recombinant Human Follicle-stimulating Hormone Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Recombinant Human Follicle-stimulating Hormone Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 31 Dec 2022

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Human Follicle-stimulating Hormone market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Recombinant Human Follicle-stimulating Hormone Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Recombinant Human Follicle-stimulating Hormone Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Human Follicle-stimulating Hormone market size was valued at USD 1075.9 million in 2023 and is forecast to a readjusted size of USD 1550.5 million by 2030 with a CAGR of 5.4% during review period.

Product Tags

recombinant human follicle stimulating hormone

Recombinant Human Follicle-stimulating Hormone

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>